Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
about
Biomarkers of risk to develop lung cancer in the new screening eraEmerging blood-based biomarkers for detection of gastric cancerCancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancerIdentification of novel autoantibodies for detection of malignant mesotheliomaEarly lung cancer diagnosis by biosensors.Advances in proteomic strategies toward the early detection of lung cancerAutoantibody approach for serum-based detection of head and neck cancer.Autoantibodies as potential biomarkers for breast cancer.Peptides from the variable region of specific antibodies are shared among lung cancer patients.Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma.Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokersLung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer.Identification of lung cancer with high sensitivity and specificity by blood testing.Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma.Serum autoantibody measurement for the detection of hepatocellular carcinomaTechnical validation of an autoantibody test for lung cancer.Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis.Clinical validation of an autoantibody test for lung cancer.Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancerEarly detection of NSCLC with scFv selected against IgM autoantibody.Autoantibodies against p53 are associated with chromosome 17p deletions in chronic lymphocytic leukemia.Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.A novel autoantibody test for the detection of pre-neoplastic lung lesionsDevelopment of a multiplex autoantibody test for detection of lung cancerApplications of protein microarrays for biomarker discovery.Autoantibody signatures: progress and perspectives for early cancer detectionAutoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.Identification of cancer-specific motifs in mimotope profiles of serum antibody repertoireApplication of serum NY-ESO-1 antibody assay for early SCLC diagnosis.Early detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer.Antibody profiling with protein antigen microarrays in early stage cancer.Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancerThe state of molecular biomarkers for the early detection of lung cancer.Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinomaUsage of cancer associated autoantibodies in the detection of diseaseAberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay.Genomic and proteomic biomarkers for cancer: a multitude of opportunities.
P2860
Q26747784-1D158514-5B97-49A3-8B39-308B0A893D78Q26778026-D3DD4706-42CD-40DD-880E-F870ECE9918EQ28273809-8E633261-2BFF-449C-984A-EBB2060C8972Q28387447-A31E8318-6CD9-481B-9412-53C68EC871F6Q30449799-54C1B2D4-B5DE-4AF7-BE85-80D6626E2E9BQ31008766-6D91AB0A-EF08-45BC-98DC-106071B96E85Q33305783-ABA44F95-D701-4810-8AB4-0BB8FA936E2BQ33332063-870060E2-67AC-4BBF-B9E8-560039CED011Q33553735-77844AEB-8FE6-4B92-A1B4-1CCDF7AC6E3DQ33586795-0D18066B-9DA6-47FB-9922-807B592A5AF8Q33588113-996A6FF1-080E-4233-BDE4-72DE719B71BBQ33602904-4B6545C3-E08E-4573-B57F-2A4C3DA00FACQ33705551-4EDC08EF-292C-4652-820A-B590C33652D7Q33829604-7BCA68C3-DC75-47A4-8D33-3D3737E687E2Q33967422-0B29C6CA-FE30-4E50-B312-A8290B6948FEQ34004797-16945CE2-8282-4FE3-9426-DB1F9BBB9BDCQ34024944-AD3C2081-7849-4845-9CCC-C3AC52DA1135Q34030497-4453D545-C472-440B-8FEF-498D8141A52CQ34309299-5EF9D32C-6E49-47CD-ABA7-F2E4A851E172Q34537374-4463B66F-12E4-4632-97E8-B84B5D1307A8Q34660278-AC46D286-9780-4C2E-9675-544D2DF04A6EQ34667869-C7C5B341-7965-4C6C-8596-15BEC3775213Q35049753-6964AB34-6935-419F-A3EF-3A4C22F5776AQ35104929-46411AF0-C2F3-468F-8923-74B6A7629E3DQ35141435-203E21D8-050F-4FEB-BEDF-600F3432B8BFQ35154906-BF8D5CD2-DC80-48FD-A982-F67852617CAFQ35170387-D4DF707A-D2EE-4658-8E99-BEDBF4CFE0EDQ35377236-34CB95D6-38CF-40DA-AFD7-0E94EEFB61A2Q35558939-000C0021-5028-488C-8FC7-5B30797AE0C8Q36285345-23A50594-4D6F-4B00-B8CA-AD611FF8A6C1Q36406087-AE9FE7A6-9EAD-43F1-8466-78021BE72DF2Q36464730-6D5ED271-47E3-4A75-AB69-6968C3F5543CQ36557829-4B07EAD5-A073-4304-A4DA-BA9736A400ACQ36682206-0F5FF154-5E52-4C32-B927-FF306671CB31Q36896106-FE9B70F9-CF07-470C-8C16-B082253FD094Q37044593-8F99FB4A-D5B6-495C-990D-41C5888D0A8FQ37212230-14E2D4E4-922C-404E-8632-45C1220B6784Q37217734-4AD5E3CD-BC48-4F77-8A2F-DFF1A7517828Q37253388-AC8AEEB4-6891-45ED-8241-D8BA0CCA8E39Q37363928-63E18078-581F-459D-9965-A02E6AA16800
P2860
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
@ast
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
@en
type
label
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
@ast
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
@en
prefLabel
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
@ast
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
@en
P2093
P1476
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
@en
P2093
Arnold J Stromberg
Edward A Hirschowitz
James R Jett
Nada H Khattar
Sarah P Coe
P304
P577
2006-07-01T00:00:00Z